Toujeo SoloStar 300 unités/ml
Toujeo SoloStar 300 unités/ml is a medicine authorised by Swissmedic under authorisation number 65453. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 November 2015 and the authorisation is valid without a time limit. ATC code A10AE04 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 65453 |
|---|---|
| Name | Toujeo SoloStar 300 unités/ml |
| Full name | Toujeo SoloStar 300 unités/ml, solution injectable en stylo pré-rempli |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AE04 |
| First authorisation | 05 November 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Toujeo SoloStar 300 unités/ml, solution injectable en stylo pré-rempli | B | 05 November 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 3 x 1.5 | ml | A10AE04 | 07.06.1. | B |
| 2 | 5 x 1.5 | ml | A10AE04 | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Toujeo SoloStar 300 unités/ml authorised in Switzerland?
Yes. Toujeo SoloStar 300 unités/ml is authorised by Swissmedic under authorisation number 65453, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Toujeo SoloStar 300 unités/ml have?
Toujeo SoloStar 300 unités/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Toujeo SoloStar 300 unités/ml?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.